Symmetric Anti-HCV Agents: Synthesis, Antiviral Properties, and Conformational Aspects of Core Scaffolds

• Alaa R. S. Leila,
• Mai H. A. Mousa,
• Efseveia Frakolaki,
• Niki Vassilaki,
• Ralf Bartenschlager,
• Grigoris Zoidis,
• Mohammad Abdel-Halim,
• Ashraf H. Abadi

Affiliations

Alaa R. S. Leila

Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt

Mai H. A. Mousa

Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt

Efseveia Frakolaki

Molecular Virology Laboratory, Hellenic Pasteur Institute, Athens, Greece

Niki Vassilaki

Molecular Virology Laboratory, Hellenic Pasteur Institute, Athens, Greece

Ralf Bartenschlager

Department of Infectious Diseases, Molecular Virology, University of Heidelberg, Heidelberg, Germany

Grigoris Zoidis

School of Health Sciences, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, University of Athens, Athens, Greece

Mohammad Abdel-Halim

Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt

Ashraf H. Abadi

Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt